SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-006392
Filing Date
2024-01-25
Accepted
2024-01-25 06:01:38
Documents
1
Period of Report
2024-01-22

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm243935-7_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm243935-7_4seq1.xml 4 5978
  Complete submission text file 0001104659-24-006392.txt   7750
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Issuer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ARYX THERAPEUTICS,INC. 6300 DUMBARTON CIRCLE FREMONT CA 94555
Business Address
Varian John (Reporting) CIK: 0001416176 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 24558450